Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies

Sudeep Banerjee
DOI: https://doi.org/10.1016/j.soc.2023.12.010
IF: 2.402
2024-01-28
Surgical Oncology Clinics of North America
Abstract:• Cost-effectiveness analysis is a rigorous methodology to compare cost, quality of life, and outcomes, including overall survival, among comparable interventions. • Next-generation sequencing can be cost-effective compared with single gene testing by reducing the need for multiple individual genetic tests and reducing time to diagnosis. • Genomic profiling can provide information that promotes value-driven therapy, particularly when biomarkers predict poor response to traditional therapies potentially Cost-effectiveness analysis is a rigorous methodology to compare cost, quality of life, and outcomes, including overall survival, among comparable interventions. Next-generation sequencing can be cost-effective compared with single gene testing by reducing the need for multiple individual genetic tests and reducing time to diagnosis. Genomic profiling can provide information that promotes value-driven therapy, particularly when biomarkers predict poor response to traditional therapies potentially
oncology,surgery
What problem does this paper attempt to address?